Effect and mechanism of psychobiotics in regulating chronic stress induced depression and constipation

  • ZOU Renying ,
  • ZHU Huiyue ,
  • XU Mengshu ,
  • TIAN Peijun ,
  • ZHANG Hao ,
  • ZHAO Jianxin ,
  • CHEN Wei ,
  • WANG Gang
Expand
  • School of Food Science and Technology, Jiangnan University Wuxi, 214122, China

Received date: 2020-08-27

  Revised date: 2020-09-15

  Online published: 2021-03-08

Abstract

“Psychobiotics” are a class of probiotics that have regulatory effects on neurobehavioral functions. With the maturity of the “microbiota-gut-brain axis” theory, psychobiotics have been widely used in the prevention and treatment of psychiatric diseases. In this study, mice under the chronic unpredictable mild stimulus (CUMS) were treated with multiple probiotics (Bifidobacterium breve CCFM1025, Bifidobacterium infantis CCFM687, and Pediococcus lactis CCFM6432) for four weeks. Multiple probiotics intervention improved the sucrose preference, reduced the immobile time in forced swim test, and increased the activity in open arms of elevated plus maze of the chronically stressed mice. The mechanism of action correlated with the down-regulation of serum corticosterone and pro-inflammatory cytokines (TNF-α and IL-1β) in the prefrontal cortex. Chronically stressed mice also showed significant constipation symptoms. Probiotics treatment increased the defecation speed which was possibly through the elevation of cecum short-chain fatty acids, 5-hydroxytryptamine (5-HT) and Htr4 gene expression. Besides, significantly positive correlations were observed between the intestinal L-tryptophan (L-Trp) and brain L-Trp/5-HT levels in the mice treated with probiotics, which indicates that the regulation of intestinal and brain L-Trp/5-HT synthesis may contribute to both constipation and depression. This study confirms the psychobiotic potential of the multiple probiotics, expands the application of probiotics, and provides novel insight for the treatment of depression and accompanied constipation.

Cite this article

ZOU Renying , ZHU Huiyue , XU Mengshu , TIAN Peijun , ZHANG Hao , ZHAO Jianxin , CHEN Wei , WANG Gang . Effect and mechanism of psychobiotics in regulating chronic stress induced depression and constipation[J]. Food and Fermentation Industries, 2021 , 47(3) : 1 -9 . DOI: 10.13995/j.cnki.11-1802/ts.025503

References

[1] CRYAN J F,O'RIORDAN K J,COWAN C S M,et al.The Microbiota-gut-brain axis[J].American Physiological Society,2019,99(4):1 877-2 013.
[2] TIAN Peijun,WANG Gang,ZHAO Jianxin,et al.Bifidobacterium with the role of 5-hydroxytryptophan synthesis regulation alleviate the symptom of depression and related microbiota dysbiosis[J].The Journal of Nutritional Biochemistry 2019,66:43-51.
[3] DIMIDI E,CHRISTODOULIDES S,SCOTT S M,et al.Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation[J].Advances in Nutrition,2017,8(3):484-494.
[4] WANG Linlin,HU Lujun,XU Qi,et al.Bifidobacterium adolescentis exerts strain-specific effects on constipation induced by loperamide in BALB/c mice[J].International Journal of Molecular Sciences,2017,18(318):1-22.
[5] MOEZI P,SALEHI A,MOLAVI H,et al.Prevalence of chronic constipation and its associated factors in pars cohort study:A study of 9 000 adults in southern iran[J].Middle East Journal of Digestive Diseases,2018,10(2):75-83.
[6] 张郭莺,蒋燕萍,胡慧玲.构建慢传输型便秘与慢性应激抑郁模型大鼠:揭示便秘与抑郁的关系[J].中国组织工程研究,2015,19(27):4 356-4 360.
ZHANG G Y,JIANG Y P,HU H L.Establishing rat models of slow transit constipation and chronic stress-induced depression:Correlation of constipation and depression[J].Chinese Journal of Tissue Engineering Research,2015,19(27):4 356-4 360.
[7] 王琳,胡筱峰,宋梅芹.精神科约束保护住院患者便秘原因分析及护理[J].齐鲁护理杂志,2012,18(7):46-47.
WANG L,HU X F,SONG M Q.Analysis of the causes and care of constipation in psychiatric restraint protection inpatients[J].Journal of Qilu Nursing,2012,18(7):46-47.
[8] 郭静尹,李慧民,徐光耀.结肠黑变病42例内窥镜检查与相关致病因素分析[J].中国医药导刊,2017,19(3):270-271.
GUO Y N,LI H M,XU G Y.Analysis of endoscopic examination in 42 cases of melanosis coli and related pathogenic factors[J].Chinese Journal of Medical Guide,2017,19(3):270-271.
[9] SEONG-EUN K,CHEI C S,SIK P K,et al.Change of fecal flora and effectiveness of the short-term VSL#3 probiotic treatment in patients with functional constipation[J].Journal of Neurogastroenterology & Motility,2015,21(1):111-120.
[10] WAITZBERG D L,FLÁVIO A Q,MICHZPUTEN S,et al.The effect of probiotic fermented milk that includes Bifidobacterium lactis CNCM I-2494 on the reduction of gastrointestinal discomfort and symptoms in adults:A narrative review[J].Nutricion Hospitalaria,2015,32(2):501-509.
[11] MUHAMMED M,KALYANAM N,SIVAKUMAR A,et al.Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome:A randomised,double-blind,placebo controlled,multi-centre,pilot clinical study[J].Food & Nutrition Research,2018,62:1-15.
[12] PINTO-SANCHEZ M I,HALL G B,GHAJAR K,et al.Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity:A pilot study in patients with irritable bowel syndrome[J].Gastroenterology,2017,153(2):448-459.
[13] LOGAN R W,EDGAR N,GILLMAN A G,et al.Chronic stress induces brain region-specific alterations of molecular rhythms that correlate with depression-like behavior in mice[J].Biol Psychiatry,2015,78(4):249-58.
[14] ZHANG Ruyi,GUO Liting,JI Zhouye,et al.Radix scutellariae attenuates CUMS-Induced depressive-like behavior by promoting neurogenesis via cAMP/PKA pathway[J].Neurochemical Research 2018,43(11):2 111-2 120.
[15] DESBONNET L,GARRETT L,CLARKE G,et al.Effects of the probiotic Bifidobacterium infantis in the maternal seperation model of depression[J].Neuroscience,2010,170:1 179-1 188.
[16] 王琳琳.双歧杆菌对便秘的影响及其作用机理研究[D].无锡:江南大学,2017.
WANG L L.Study of the effects and mechanisms of bifidobacterial on constipation alleviation[D].Wuxi:Jiangnan University,2017.
[17] XU Nana,FAN Wenting,ZHOU Xiaoyan,et al.Probiotics decrease depressive behaviors induced by constipation via activating the AKT signaling pathway[J].Metabolic Brain Disease,2018,33(5):1 625-1 633.
[18] NAGAKURA Y,NAITOH Y,KAMATO T,et al.Compounds possessing 5-HT3 receptor antagonistic activity inhibit intestinal propulsion in mice[J].Eur J Pharmacol,1996,311:67-72.
[19] 杨家丽,曾西,王晓敏,等.5-HTP和5-HT含量测定方法的建立[J].广西医科大学学报,2015,32(6):1 007-1 009.
YANG J L,ZENG X,WANG X M.Establishment of methods for the determination of 5-HTP and 5-HT content[J].Journal of Guangxi Medical University,2015,32(6):1 007-1 009.
[20] 毛丙永.功能性低聚糖对肠道细菌的影响及机制[D].无锡:江南大学,2015.
MAO B Y.Effects of functional oligosaccharides on the gut bacteria and the mechanism[D].Wuxi:Jiangnan University,2015.
[21] ISMAIL Z,ELBAYOUMI H,FISCHER C E,et al.Prevalence of depression in patients with mild cognitive impairment:A systematic review and meta-analysis[J].JAMA Psychiatry,2017,74:58-67.
[22] GARVEY M,NOYES R,YATES W.Frequency of constipation in major depression[J].Psychosomatics,1990,31(2):204-206.
[23] JACOBSEN J P,MEDVEDEV I O,CARON M G.The 5-HT deficiency theory of depression:perspectives from a naturalistic 5-HT deficiency model,the tryptophan hydroxylase 2Arg439His knockin mouse[J].Philos Trans R Soc Lond B Biol Sci,2012,367(1601):2 444-2 459.
[24] HOLCK A,WOLKOWITZ O M,MELLON S H,et al.Plasma serotonin levels are associated with antidepressant response to SSRIs[J].Journal of Affective Disorders,2019,250:65-70.
[25] SAPOLSKY R M,UNO H,REBERT C S,et al.Hippocampal damage associated with prolonged glucocorticoid exposure in primates[J].The Journal of Neuroscience,1990,10(9):2 897-2 902.
[26] WERMERSKIRCHEN A S,LATOCHA D H,CLARKE B L.Adrenocorticotropic hormone controls concanavalin A activation of rat lymphocytes by modulating IL-2 production[J].Life Sciences,2000,67:2 177-2 187.
[27] BELVEDERI M M,PARIANTE C,MONDELLI V,et al.HPA axis and aging in depression:Systematic review and meta-analysis[J].Psychoneuroendocrinology,2014,41:46-62.
[28] PERRIN A J,PARIANTE C M.Endocrine and immune effects of non-convulsive neurostimulation in depression:A systematic review[J].Brain,Behavior,and Immunity,2020,87:910-920.
[29] COLLINS B R,O'BRIEN L.Prevention and management of constipation in adults[J].Nursing Standard,2015,29(32):49-58.
[30] SPENCER N J.Constitutively active 5-HT receptors:An explanation of How 5-HT antagonists inhibit gut motility in species where 5-HT is not an enteric neurotransmitter?[J].Front Cell Neurosci,2015,9:487-492.
[31] 陈小燕,周礼鲲,柯美云.5-HT受体激动剂和拮抗剂及其在功能性胃肠病中的应用[J].中国处方药,2005,44(11):43-45.
CHEN X Y,ZOU L K,KE M Y.5-HT receptor agonist,antagonist and its application in functional gastrointestinal disorders[J].China Perscription Drug,2005,44(11):43-45.
[32] FUKUDO S,NAKAMURA M,HAMATANI T,et al.Efficacy and safety of 5-HT4 receptor agonist minesapride for irritable bowel syndrome with constipation in a randomized controlled trial[J].Clin Gastroenterol Hepatol,2020.DOI:10.1016/j.cgh.2020.03.019.
[33] DASS N B,JOHN A K,BASSIL A K,et al.The relationship between the effects of short-chain fatty acids on intestinal motility in vitro and GPR43 receptor activation[J].Neurogastroenterol Motil,2007,19(1):66-74.
[34] 张树成,张海兰,王维林.功能性便秘儿童粪便短链脂肪酸的气相色谱分析及临床意义[J].中华小儿外科杂志,2010,31(4):276-278.
ZHANG S C,ZHANG H L,WANG W L.Establishment of the finger-print of the short chain fatty acid in human fecal samples based on gas chromatography in functional constipation in childhood[J].Chinese Journal of Pediatric Surgery,2010,31(4):276-278.
[35] OHARA T,SUZUTANI T.Efficacy of fecal microbiota transplantation in a patient with chronic intractable constipation[J].Clin Case Rep,2018,6(11):2 029-2 032.
[36] HURST N R,KENDIG D M,MURTHY K S,et al.The short chain fatty acids,butyrate and propionate,have differential effects on the motility of the guinea pig colon[J].Neurogastroenterology & Motility,2014,26(11):1 586-1 596.
[37] MACFARLANE G T,MACFARLANE S,GIBSON G R.Validation of a three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon[J].Microbial Ecology,1998,35:180-187.
[38] YANO J M,YU K,DONALDSON G P,et al.Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis[J].Cell,2015,161(2):264-276
[39] O'REARDON J P,CHOPRA M P,BERGAN A,et al.Response to tryptophan depletion in major depression treated with either cognitive therapy or selective serotonin reuptake inhibitor antidepressants[J].Biol Psychiatry,2004,55(9):957-959.
[40] HAYNES P L,MCQUAID J R,KELSOE J,et al.Affective state and EEG sleep profile in response to rapid tryptophan depletion in recently recovered nonmedicated depressed individuals[J].Journal of Affective Disorders,2004,83(3):253-262.
Outlines

/